Exploring how glaucoma affects mobility in older adults
Glaucoma, Visual Field Loss, and Their Association With Life Space in Older Adults
This study looks at how glaucoma affects the ability of older adults to move around, especially in low light, by comparing those with glaucoma to those with healthy eyesight.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years to 100 Years |
| Sex | All |
| Sponsor | University of Alabama at Birmingham Academic / other |
| Locations | 1 site (Birmingham, Alabama) |
| Trial ID | NCT04396002 on ClinicalTrials.gov |
What this trial studies
This observational study investigates the relationship between primary open-angle glaucoma (POAG) and mobility in older adults. It aims to assess how visual impairments associated with POAG, particularly under low illumination, impact life space, which refers to the extent of a person's mobility. The study will utilize various questionnaires and objective measures to evaluate visual function and its correlation with mobility. By comparing individuals with POAG to those with healthy eyes, the research seeks to provide insights into the mobility challenges faced by older adults with this condition.
Who should consider this trial
Good fit: Ideal candidates include older adults diagnosed with primary open-angle glaucoma who are enrolled in specific NIH-funded studies.
Not a fit: Patients not enrolled in the specified NIH-funded studies or those with cognitive impairments may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of mobility issues in older adults with glaucoma, potentially leading to improved management strategies.
How similar studies have performed: While there is limited direct research on this specific relationship, existing studies have indicated mobility challenges in glaucoma patients, suggesting that this approach may yield valuable insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria (Patients): * Participants that are enrolled in the Early Detection of Glaucoma Progression using a Novel Individualized Approach (IRB-300000301) or in the African Descent and Glaucoma Evaluation (ADAGES) IV: Alterations of the Lamina Cribrosa in Progression (IRB-161115004). Exclusion Criteria (Patients): * Not being enrolled in one of the following two NIH-funded studies: 1. African Descent and Glaucoma Evaluation (ADAGES) IV: Alterations of the lamina cribrosa in progression (EY026574) or 2. Early detection of glaucoma progression using a novel individualized approach (EY025756) Inclusion Criteria (Controls): * No diagnosis of eye disease Exclusion Criteria (Controls): * Cognitive impairment that would preclude ability to take the tests
Where this trial is running
Birmingham, Alabama
- University of Alabama Birmingham — Birmingham, Alabama, United States (Recruiting)
Study contacts
- Principal investigator: Lyne Racette, PhD — University of Alabama at Birmingham
- Study coordinator: Lyne Racette, PhD
- Email: lracette@uabmc.edu
- Phone: 205-325-8673
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.